Radiation oncology firm Elekta has issued a bond worth 1 billion Swedish kronor ($117.6 million U.S.).
The bond has a five-year maturity term, according to the firm, and is split into two portions: fixed and floating. The first portion consists of 300 million kronor ($35.3 million) with a fixed annual interest rate of 1.58%, while the second consists of 700 million kronor ($82.3 million) with a floating interest rate of three months at the Stockholm Interbank Offered Rate (STIBOR), plus an interest margin of 1.2% paid quarterly, Elekta said.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
